A previous study has shown that the overexpression of constitutively active GSK-3β in cultured cardiomyocytes attenuate cardiac hypertrophy induced by hypertrophic agents such as ET-1 and phenylephrine by blocking the NFAT nuclear translocation (25). The gene discussed is GSK3B; the disease is cardiac hypertrophy.